Protease‐activated receptor 2 in dorsal root ganglion contributes to peripheral sensitization of bone cancer pain

These findings suggest that PAR2 may be a key mediator for peripheral sensitization of bone cancer pain. Inhibiting PAR2 activation, especially during the early phase, may be a new therapy for preventing/suppressing development of bone cancer pain.